56 studies found for:    "autosomal recessive cerebellar ataxia type 1" OR "Cerebellar Ataxia"
Show Display Options
RSS Create an RSS feed from your search for:
"autosomal recessive cerebellar ataxia type 1" OR "Cerebellar Ataxia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
Conditions: Hereditary Ataxia;   Multiple Sclerosis;   Cerebellar Ataxia
Interventions: Drug: Riluzole;   Other: placebo
2 Completed Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia
Conditions: Celiac Disease;   Cerebellar Ataxia;   Healthy
Intervention:
3 Recruiting Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia
Condition: Cerebellar Ataxia
Intervention: Biological: Intravenous transfer of of Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs)
4 Unknown  SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Conditions: Cerebellar Ataxias;   Spastic Paraplegias
Intervention:
5 Enrolling by invitation A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation
Condition: Hereditary Cerebellar Ataxia.
Intervention: Other: stem cell transplantation
6 Completed Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells
Condition: Cerebellar Ataxia
Intervention: Biological: Allogeneic adult adipose-derived mesenchymal stem cells
7 Completed Exercise Training Program for Cerebellar Ataxia
Condition: Cerebellar Ataxia
Intervention: Behavioral: Home exercise program
8 Unknown  Efficacy of Riluzole in Hereditary Cerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Drug: riluzole;   Other: Placebo comparator
9 Completed Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias
Conditions: Congenital Cerebellar Ataxias;   Early-onset Cerebellar Ataxias
Intervention: Genetic: blood sample
10 Active, not recruiting Biomarkers in Autosomal Dominant Cerebellar Ataxia
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia, Autosomal Recessive 3;   Episodic Ataxia, Type 7
Intervention: Other: metabolic and imaging biomarkers in SCA1,2,3 and 7 patients
11 Recruiting Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Device: Transcranial Magnetic Stimulation
12 Completed High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration
Condition: Spinocerebellar Degenerations
Intervention: Drug: high-dose intravenous immunoglobulin (IVIG)
13 Recruiting Stiff Person Syndrome (SPS)
Condition: Stiff Person Syndrome
Intervention: Biological: Autologous Hematopoietic Stem Cell Transplantation
14 Not yet recruiting Pancreatic Cancer Screening of High-Risk Residents of Arkansas
Conditions: Pancreatic Neoplasms;   Peutz-Jegher's Syndrome;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ataxia Telangiectasia;   Familial Atypical Mole-Malignant Melanoma Syndrome;   Colorectal Neoplasms, Hereditary Nonpolyposis;   Hereditary Pancreatitis
Intervention: Other: Pancreatic Cancer Screening
15 Completed The Effect of Whole Body Vibration Training on Neuromuscular Property in Individuals With Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Other: Whole body vibration training
16 Active, not recruiting Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10
Condition: Ataxia-oculomotor Apraxia 1
Interventions: Dietary Supplement: CoQ10;   Other: Sanomit Placebo
17 Completed Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
Condition: SPINOCEREBELLAR ATAXIA 2
Intervention: Drug: LITHIUM CARBONATE
18 Not yet recruiting An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
Condition: Spinocerebellar Ataxias
Intervention: Drug: Intravenous Immune Globulin (IVIG)
19 Withdrawn Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
Condition: Spinocerebellar Ataxia Type 3
Interventions: Drug: Placebo;   Drug: Sodium Phenylbutyrate
20 Completed Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias
Condition: Spinocerebellar Ataxia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years